Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{152387,
        author = {Gawali Vijay Appu and Dipak A. Joshi and Shyamlila B. Bavage and Nandkishor B. Bavage},
        title = {ADVERSE DRUG EVENT REPORTING OF REMDESIVIR},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {8},
        number = {3},
        pages = {159-161},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=152387},
        abstract = {Purpose; Remdesivir shows promise in the treatment of COVID19 patients. Despite this, it is still necessary to record potential drug side effects (PBL) for future decision-making. Same as the limited ADE data available before the COVID19 pandemic.},
        keywords = {},
        month = {},
        }